BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 19405992)

  • 1. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.
    Lampen A; Zhang Y; Hackbarth I; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1104-12. PubMed ID: 9618413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human small intestinal cytochromes P-450.
    Zhang QY; Dunbar D; Ostrowska A; Zeisloft S; Yang J; Kaminsky LS
    Drug Metab Dispos; 1999 Jul; 27(7):804-9. PubMed ID: 10383924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions between food and drugs. 2. Disturbances of drug metabolism and synergistic mode of action].
    Jarosz M; Dzieniszewski J
    Pol Merkur Lekarski; 2000 Nov; 9(53):795-8. PubMed ID: 11204334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism by cytochromes P450 in the liver and small bowel.
    Watkins PB
    Gastroenterol Clin North Am; 1992 Sep; 21(3):511-26. PubMed ID: 1516957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
    Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug metabolism in the small intestine--the significance for biological availability].
    Andersen VC; Sonne J
    Ugeskr Laeger; 2000 May; 162(22):3215-9. PubMed ID: 10850220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
    Murray M
    Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep.
    Maté L; Virkel G; Lifschitz A; Sallovitz J; Ballent M; Lanusse C
    J Vet Pharmacol Ther; 2010 Dec; 33(6):537-45. PubMed ID: 21062305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and hepatic expression profiles of cytochrome P450 1-4 isozymes in common minke whales (Balaenoptera acutorostrata).
    Niimi S; Kim EY; Iwata H; Watanabe MX; Yasunaga G; Fujise Y; Tanabe S
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):667-81. PubMed ID: 17526421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
    Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
    Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.
    Nishimuta H; Sato K; Mizuki Y; Yabuki M; Komuro S
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):300-6. PubMed ID: 21383522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?
    Doherty MM; Charman WN
    Clin Pharmacokinet; 2002; 41(4):235-53. PubMed ID: 11978143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.
    Martignoni M; Groothuis G; de Kanter R
    Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative metabolism of foreign compounds in rat small intestine: cellular localization and dependence on dietary iron.
    Hoensch H; Woo CH; Raffin SB; Schmid R
    Gastroenterology; 1976 Jun; 70(6):1063-70. PubMed ID: 817959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mouse small intestinal cytochrome P450 expression.
    Zhang QY; Dunbar D; Kaminsky LS
    Drug Metab Dispos; 2003 Nov; 31(11):1346-51. PubMed ID: 14570766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.
    Patel JP; Brocks DR
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1385-98. PubMed ID: 19663632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.